GENEDX HOLDINGS CORP (WGS)
US81663L2007 - Common Stock
Overall WGS gets a fundamental rating of 3 out of 10. We evaluated WGS against 113 industry peers in the Health Care Providers & Services industry. The financial health of WGS is average, but there are quite some concerns on its profitability. WGS is valued quite expensive, but it does show an excellent growth.
1. Profitability
1.1 Basic Checks
WGS had negative earnings in the past year.
WGS had a negative operating cash flow in the past year.
In the past 5 years WGS always reported negative net income.
WGS had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of -20.42%, WGS is doing worse than 77.88% of the companies in the same industry.
With a Return On Equity value of -40.83%, WGS is not doing good in the industry: 66.37% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -20.42% | ||
| ROE | -40.83% | ||
| ROIC | N/A |
ROA(3y)-66.03%
ROA(5y)-62.01%
ROE(3y)-118.9%
ROE(5y)-1173.25%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
With an excellent Gross Margin value of 59.48%, WGS belongs to the best of the industry, outperforming 81.42% of the companies in the same industry.
WGS's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for WGS so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 59.48% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y7.53%
2. Health
2.1 Basic Checks
WGS does not have a ROIC to compare to the WACC, probably because it is not profitable.
WGS has more shares outstanding than it did 1 year ago.
The debt/assets ratio for WGS is higher compared to a year ago.
2.2 Solvency
Based on the Altman-Z score of 1.67, we must say that WGS is in the distress zone and has some risk of bankruptcy.
WGS's Altman-Z score of 1.67 is in line compared to the rest of the industry. WGS outperforms 50.44% of its industry peers.
A Debt/Equity ratio of 0.25 indicates that WGS is not too dependend on debt financing.
The Debt to Equity ratio of WGS (0.25) is better than 66.37% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.25 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 1.67 |
ROIC/WACCN/A
WACC8.98%
2.3 Liquidity
A Current Ratio of 2.41 indicates that WGS has no problem at all paying its short term obligations.
WGS's Current ratio of 2.41 is amongst the best of the industry. WGS outperforms 83.19% of its industry peers.
A Quick Ratio of 2.27 indicates that WGS has no problem at all paying its short term obligations.
WGS has a Quick ratio of 2.27. This is amongst the best in the industry. WGS outperforms 81.42% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.41 | ||
| Quick Ratio | 2.27 |
3. Growth
3.1 Past
WGS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 91.79%, which is quite impressive.
The Revenue has grown by 29.41% in the past year. This is a very strong growth!
The Revenue has been growing by 8.73% on average over the past years. This is quite good.
EPS 1Y (TTM)91.79%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%104.88%
Revenue 1Y (TTM)29.41%
Revenue growth 3Y4.15%
Revenue growth 5Y8.73%
Sales Q2Q%44.22%
3.2 Future
The Earnings Per Share is expected to grow by 30.87% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 26.60% on average over the next years. This is a very strong growth
EPS Next Y94.4%
EPS Next 2Y44.52%
EPS Next 3Y30.87%
EPS Next 5YN/A
Revenue Next Year48.04%
Revenue Next 2Y31.48%
Revenue Next 3Y26.6%
Revenue Next 5YN/A
3.3 Evolution
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
WGS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Based on the Price/Forward Earnings ratio of 159.04, the valuation of WGS can be described as expensive.
WGS's Price/Forward Earnings is on the same level as the industry average.
When comparing the Price/Forward Earnings ratio of WGS to the average of the S&P500 Index (24.00), we can say WGS is valued expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 159.04 |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
WGS's earnings are expected to grow with 30.87% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y44.52%
EPS Next 3Y30.87%
5. Dividend
5.1 Amount
WGS does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
GENEDX HOLDINGS CORP
NASDAQ:WGS (11/22/2024, 8:00:02 PM)
After market: 78.7401 +0.03 (+0.04%)78.71
+6.64 (+9.21%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap2.16B
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 159.04 | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -20.42% | ||
| ROE | -40.83% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 59.48% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.65
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.25 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 2.41 | ||
| Quick Ratio | 2.27 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)91.79%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y94.4%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)29.41%
Revenue growth 3Y4.15%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y